- About Qutenza®
- Qutenza® Treatment
- About PHN
- Request Training
Indication: Qutenza® (capsaicin) 8% patch is indicated for the management of neuropathic pain associated with postherpetic neuralgia.
Only physicians or healthcare professionals under the close supervision of a physician are to administer Qutenza®.
Warnings and Precautions:
Adverse Reactions: In clinical trials, serious adverse reactions included application-associated pain and increase in blood pressure. The most common adverse reactions (≥ 5% and greater than control) were application-site erythema, application-site pain, application-site pruritus, and application-site papules.
For additional information, please click here for full Prescribing Information.